159 related articles for article (PubMed ID: 1777653)
1. Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study.
Groop LC; Ratheiser K; Luzi L; Melander A; Simonson DC; Petrides A; Bonadonna RC; Widén E; DeFronzo RA
Acta Diabetol; 1991; 28(2):162-8. PubMed ID: 1777653
[TBL] [Abstract][Full Text] [Related]
2. Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Groop L; Luzi L; Melander A; Groop PH; Ratheiser K; Simonson DC; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1320-8. PubMed ID: 3117609
[TBL] [Abstract][Full Text] [Related]
3. Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
Ahrén B; Lundquist I; Scherstén B
Diabetes Res; 1986 Jul; 3(6):293-300. PubMed ID: 3530592
[TBL] [Abstract][Full Text] [Related]
4. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
[TBL] [Abstract][Full Text] [Related]
5. Effect of glipizide on insulin secretion and insulin metabolism in obese type II diabetic patients.
Bonora E; Pisani F; Micciolo R; Corgnati A; Muggeo M
Diabetes Care; 1987; 10(6):687-91. PubMed ID: 3322723
[TBL] [Abstract][Full Text] [Related]
6. The acute effect of preprandial exogenous and endogenous sulphonylurea-stimulated insulin secretion on postprandial glucose excursions in patients with type 2 diabetes.
Groop PH; Melander A; Groop LC
Diabet Med; 1993; 10(7):633-7. PubMed ID: 8403824
[TBL] [Abstract][Full Text] [Related]
7. Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man.
Bratusch-Marrain PR; Vierhapper H; Komjati M; Waldhäusl WK
Diabetologia; 1985 Sep; 28(9):671-6. PubMed ID: 3905478
[TBL] [Abstract][Full Text] [Related]
8. Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.
Scheen AJ; Lefebvre PJ; Luyckx AS
Eur J Clin Pharmacol; 1984; 26(4):471-4. PubMed ID: 6376145
[TBL] [Abstract][Full Text] [Related]
9. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
10. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation.
Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ
Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus.
Bitzén PO; Melander A; Scherstén B; Svensson M; Wåhlin-Boll E
Eur J Clin Pharmacol; 1992; 42(1):77-83. PubMed ID: 1541320
[TBL] [Abstract][Full Text] [Related]
12. The plasma C-peptide and insulin responses to stimulation with intravenous glucagon and a mixed meal in well-controlled type 2 (non-insulin-dependent) diabetes mellitus: dependency on acutely established hyperglycaemia.
Gjessing HJ; Reinholdt B; Pedersen O
Diabetologia; 1989 Dec; 32(12):858-63. PubMed ID: 2693165
[TBL] [Abstract][Full Text] [Related]
13. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
14. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
Vilsbøll T; Krarup T; Madsbad S; Holst JJ
Diabetologia; 2002 Aug; 45(8):1111-9. PubMed ID: 12189441
[TBL] [Abstract][Full Text] [Related]
15. Effect of added fat on plasma glucose and insulin response to ingested potato in individuals with NIDDM.
Gannon MC; Ercan N; Westphal SA; Nuttall FQ
Diabetes Care; 1993 Jun; 16(6):874-80. PubMed ID: 8325201
[TBL] [Abstract][Full Text] [Related]
16. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of glipizide sulfonylurea action: decreased metabolic clearance rate of insulin.
Barzilai N; Groop PH; Groop L; DeFronzo RA
Acta Diabetol; 1995 Dec; 32(4):273-8. PubMed ID: 8750768
[TBL] [Abstract][Full Text] [Related]
18. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus.
Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS
J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533
[TBL] [Abstract][Full Text] [Related]
19. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects.
Kjems LL; Holst JJ; Vølund A; Madsbad S
Diabetes; 2003 Feb; 52(2):380-6. PubMed ID: 12540611
[TBL] [Abstract][Full Text] [Related]
20. Suppression of insulin secretion by falling plasma glucose levels is impaired in type 2 diabetes.
Hosker JP; Burnett MA; Matthews DR; Turner RC
Diabet Med; 1988 Dec; 5(9):856-60. PubMed ID: 2976647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
